Abstract
This chapter is intended as a primer to the most widely used neuroimaging methods available in the prediction, diagnosis and monitoring of the neurodegenerative diseases. We describe the imaging methods that allow us to examine brain structure, function and pathology and investigate neurodegenerative mechanisms in vivo. We describe methods to interrogate brain structure with magnetic resonance imaging (MRI), and brain function with molecular imaging, functional MRI and electro- and magneto-encephalography. We highlight the major neuroimaging advances, including brain stimulation and connectomics, which have brought new insights into a wide range of neurodegenerative diseases and describe some of the challenges in imaging clinical populations. Finally, we discuss the future of neuroimaging in neurodegenerative disease and its potential for generating predictive, diagnostic and prognostic biomarkers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AD:
-
Alzheimer’s disease
- aD:
-
Axial diffusivity
- BOLD:
-
Blood oxygenation level dependent
- bvFTD:
-
Behavioural-variant fronto-temporal dementia
- CBD:
-
Cortico-basal syndrome
- CT:
-
Computed tomography
- DBS:
-
Deep brain stimulation
- DTI:
-
Diffusion tensor imaging
- DWI:
-
Diffusion weighted imaging
- EEG:
-
Electroencephalography
- ERP:
-
Event-related potential
- FA:
-
Fractional anisotropy
- FDG:
-
Fluorodeoxyglucose
- FLAIR:
-
Fluid attenuated inversion recovery
- fMRI:
-
Functional magnetic resonance imaging
- HD:
-
Huntington’s disease
- HMPAO:
-
Hexamethylpropyleneamine oxime
- ICA:
-
Independent components analysis
- MCI:
-
Mild cognitive impairment
- MEG:
-
Magnetoencephalography
- MRA:
-
Magnetic resonance angiography
- MRI:
-
Magnetic resonance imaging
- MS:
-
Multiple sclerosis
- NAA:
-
N-Acetylaspartate
- PD:
-
Parkinson’s disease
- PET:
-
Positron emission tomography
- PNFA:
-
Primary non-fluent aphasia
- rD:
-
Radial diffusivity
- SD:
-
Semantic dementia
- SPECT:
-
Single-photon emission computed tomography
- SUV:
-
Standardised uptake value
- T:
-
Tesla
- TES:
-
Transcranial electrical stimulation
- TMS:
-
Transcranial magnetic stimulation
References
Ashburner J, Friston KJ (2000) Voxel-based morphometry—the methods. NeuroImage 11:805–821
Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD (2009) Neurodegenerative diseases target large-scale human brain networks. Neuron 62:42–52
Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis: I. Segmentation and surface reconstruction. Neuroimage 9:179–194
Querbes O, Aubry F, Pariente J, Lotterie J-A, Démonet J-F, Duret V, Puel M, Berry I, Fort J-C, Celsis P (2009) Early diagnosis of Alzheimer’s disease using cortical thickness: impact of cognitive reserve. Brain 132:2036–2047
Du A-T, Schuff N, Kramer JH, Rosen HJ, Gorno-Tempini ML, Rankin K, Miller BL, Weiner MW (2007) Different regional patterns of cortical thinning in Alzheimer’s disease and frontotemporal dementia. Brain 130:1159–1166
Alexander-Bloch A, Giedd JN, Bullmore E (2013) Imaging structural co-variance between human brain regions. Nat Rev Neurosci 14:322–336
Evans AC (2013) Networks of anatomical covariance. NeuroImage 80:489–504
Zhou J, Gennatas ED, Kramer JH, Miller BL, Seeley WW (2012) Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron 73:1216–1227
Bernhardt BC, Worsley KJ, Besson P, Concha L, Lerch JP, Evans AC, Bernasconi N (2008) Mapping limbic network organization in temporal lobe epilepsy using morphometric correlations: insights on the relation between mesiotemporal connectivity and cortical atrophy. NeuroImage 42:515–524
Reuter M, Tisdall MD, Qureshi A, Buckner RL, van der Kouwe AJW, Fischl B (2015) Head motion during MRI acquisition reduces gray matter volume and thickness estimates. NeuroImage 107:107–115
Reuter M, Fischl B (2011) Avoiding asymmetry-induced bias in longitudinal image processing. NeuroImage 57:19–21
Jones DK, Knösche TR, Turner R (2013) White matter integrity, fiber count, and other fallacies: the do’s and don’ts of diffusion MRI. NeuroImage 73:239–254
Johansen-Berg H, Behrens TEJ (2009) Diffusion MRI: from quantitative measurement to in-vivo neuroanatomy. In: Diffus MRI. Elsevier, Oxford. doi:10.1016/B978-0-12-374709-9.00002-X
Kantarci K, Avula R, Senjem ML et al (2010) Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology 74:1814–1821
Rosas HD, Lee SY, Bender AC et al (2010) Altered white matter microstructure in the corpus callosum in Huntington’s disease: implications for cortical “disconnection.”. NeuroImage 49:2995–3004
Tournier J-D, Mori S, Leemans A (2011) Diffusion tensor imaging and beyond. Magn Reson Med 65:1532–1556
Galantucci S, Tartaglia MC, Wilson SM et al (2011) White matter damage in primary progressive aphasias: a diffusion tensor tractography study. Brain 134:3011–3029
Jeurissen B, Leemans A, Tournier J-D, Jones DK, Sijbers J (2010) Estimating the number of fiber orientations in diffusion MRI voxels: a constrained spherical deconvolution study. Proc Int Soc Magn Reson Med 45:3536
Raffelt DA, Tournier JD, Smith RE, Vaughan DN, Jackson G, Ridgway GR, Connelly A (2017) Investigating white matter fibre density and morphology using fixel-based analysis. NeuroImage 144:58–73
Harrison NA, Cooper E, Dowell NG, Keramida G, Voon V, Critchley HD, Cercignani M (2015) Quantitative magnetization transfer imaging as a biomarker for effects of systemic inflammation on the brain. Biol Psychiatry 78:49–57
Theysohn JM, Kraff O, Maderwald S, Schlamann MU, De Greiff A, Forsting M, Ladd SC, Ladd ME, Gizewski ER (2009) The human hippocampus at 7 T—in vivo MRI. Hippocampus 19:1–7
Visser F, Zwanenburg JJM, Hoogduin JM, Luijten PR (2010) High-resolution magnetization-prepared 3D-FLAIR imaging at 7.0 tesla. Magn Reson Med 64:194–202
Zwanenburg JJM, Versluis MJ, Luijten PR, Petridou N (2011) Fast high resolution whole brain T2* weighted imaging using echo planar imaging at 7T. NeuroImage 56:1902–1907
van der Kolk AG, Hendrikse J, Zwanenburg JJM, Visser F, Luijten PR (2013) Clinical applications of 7T MRI in the brain. Eur J Radiol 82:708–718
Theysohn JM, Kraff O, Maderwald S, Barth M, Ladd SC, Forsting M, Ladd ME, Gizewski ER (2011) 7 tesla MRI of microbleeds and white matter lesions as seen in vascular dementia. J Magn Reson Imaging 33:782–791
van Rooden S, Maat-Schieman MLC, Nabuurs RJA, van der Weerd L, van Duijn S, van Duinen SG, Natté R, van Buchem MA, van der Grond J (2009) Cerebral amyloidosis: postmortem detection with human 7.0-T MR imaging system. Radiology 253:788–796
Dula AN, Virostko J, Shellock FG (2014) Assessment of MRI issues at 7 T for 28 implants and other objects. Am J Roentgenol 202:401–405
Lerch JP, van der Kouwe AJW, Raznahan A, Paus T, Johansen-Berg H, Miller KL, Smith SM, Fischl B, Sotiropoulos SN (2017) Studying neuroanatomy using MRI. Nat Neurosci 20:314–326
Bandettini PA (2009) Functional MRI limitations and aspirations. In: Kraft E, Gulyas B, Pöppel E (eds) Neural correlates of thinking. Springer, Berlin, pp 15–38
Ogawa S, Lee T-M (1990) Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation. Magn Reson Med 16:9–18
Ogawa S, Lee TM, Kay AR, Tank DW (1990) Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 87:9868–9872
Yacoub E, Shmuel A, Pfeuffer J, Van De Moortele PF, Adriany G, Ugurbil K, Hu X (2001) Investigation of the initial dip in fMRI at 7 Tesla. NMR Biomed 14:408–412
Amaro E, Barker GJ (2006) Study design in fMRI: basic principles. Brain Cogn 60:220–232
Abdulkadir A, Ronneberger O, Wolf RC, Pfleiderer B, Saft C, Kloppel S (2013) Functional and structural MRI biomarkers to detect pre-clinical neurodegeneration. Curr Alzheimer Res 10:125–134
Georgiou-Karistianis N, Stout JC, Domínguez DJF et al (2014) Functional magnetic resonance imaging of working memory in Huntington’s disease: cross-sectional data from the IMAGE-HD study. Hum Brain Mapp 35:1847–1864
Rosenow F, Lüders H (2001) Presurgical evaluation of epilepsy. Brain 124:1683–1700
Hage ZA, Alaraj A, Arnone GD, Charbel FT (2016) Novel imaging approaches to cerebrovascular disease. Transl Res 175:54–75
Veldsman M, Cumming T, Brodtmann A (2015) Beyond BOLD: optimizing functional imaging in stroke populations. Hum Brain Mapp 36:1620–1636
Biswal B, Yetkin FZ, Haughton VM, Hyde JS (1995) Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 34:537–541
Biswal BB, Mennes M, Zuo X-N et al (2010) Toward discovery science of human brain function. Proc Natl Acad Sci U S A 107:4734–4739
Greicius MD, Krasnow B, Reiss AL, Menon V (2003) Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A 100:253–258
Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL (2001) A default mode of brain function. Proc Natl Acad Sci U S A 98:676–682
Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME (2005) The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A 102:9673–9678
Fox MD, Greicius M (2010) Clinical applications of resting state functional connectivity. Front Syst Neurosci 4:19
Petrella JR, Sheldon FC, Prince SE, Calhoun VD, Doraiswamy PM (2011) Default mode network connectivity in stable vs progressive mild cognitive impairment. Neurology 76:511–517
Greicius MD, Srivastava G, Reiss AL, Menon V (2004) Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A 101:4637–4642
He BJ, Snyder AZ, Vincent JL, Epstein A, Shulman GL, Corbetta M (2007) Breakdown of functional connectivity in frontoparietal networks underlies behavioral deficits in spatial neglect. Neuron 53:905–918
Fox MD, Raichle ME (2007) Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 8:700–711
Kiviniemi V, Kantola JH, Jauhiainen J, Hyvärinen A, Tervonen O (2003) Independent component analysis of nondeterministic fMRI signal sources. NeuroImage 19:253–260
Zuo X-N, Di Martino A, Kelly C, Shehzad ZE, Gee DG, Klein DF, Castellanos FX, Biswal BB, Milham MP (2010) The oscillating brain: complex and reliable. NeuroImage 49:1432–1445
McGill ML, Devinsky O, Wang X, Quinn BT, Pardoe H, Carlson C, Butler T, Kuzniecky R, Thesen T (2014) Functional neuroimaging abnormalities in idiopathic generalized epilepsy. NeuroImage Clin 6:455–462
La C, Nair VA, Mossahebi P, Young BM, Chacon M, Jensen M, Birn RM, Meyerand ME, Prabhakaran V (2016) Implication of the slow-5 oscillations in the disruption of the default-mode network in healthy aging and stroke. Brain Connect 6:482–495
Han Y, Wang J, Zhao Z, Min B, Lu J, Li K, He Y, Jia J (2011) Frequency-dependent changes in the amplitude of low-frequency fluctuations in amnestic mild cognitive impairment: a resting-state fMRI study. NeuroImage 55:287–295
Benadiba M, Luurtsema G, Wichert-Ana L, Buchpigel CA, Filho GB (2012) New molecular targets for PET and SPECT imaging in neurodegenerative diseases. Rev Bras Psiquiatr. doi:10.1016/j.rbp.2012.07.002
Catafau AM, Bullich S (2016) Non-amyloid PET imaging biomarkers for neurodegeneration: focus on tau, alpha-synuclein and neuroinflamation. Curr Alzheimer Res 14(2):169–177
Drzezga A, Barthel H, Minoshima S, Sabri O (2014) Potential clinical applications of PET/MR imaging in neurodegenerative diseases. J Nucl Med 55:47–55
Zhu L, Ploessl K, Kung HF (2014) PET/SPECT imaging agents for neurodegenerative diseases. Chem Soc Rev 43:6683–6691
Kadir A, Nordberg A (2010) Target-specific PET probes for neurodegenerative disorders related to dementia. J Nucl Med 51:1418–1430
Mosconi L, Tsui WH, Herholz K et al (2008) Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. J Nucl Med 49:390–398
Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32:1207–1218
Villemagne VL, Doré V, Bourgeat P, Burnham SC, Laws S, Salvado O, Masters CL, Rowe CC (2017) Aβ-amyloid and tau imaging in dementia. Semin Nucl Med 47:75–88
Shah M, Catafau AM (2014) Molecular imaging insights into neurodegeneration: focus on tau PET radiotracers. J Nucl Med 55:871–874
Holman BL, Carvalho PA, Mendelson J, Teoh SK, Nardin R, Hallgring E, Hebben N, Johnson KA (1991) Brain perfusion is abnormal in cocaine-dependent polydrug users: a study using technetium-99m-HMPAO and ASPECT. J Nucl Med 32:1206–1210
Karonen JO, Nuutinen J, Kuikka JT, Vanninen EJ, Vanninen RL, Partanen PLK, Vainio PA, Roivainen R, Sivenius J, Aronen HJ (2000) Combined SPECT and diffusion-weighted MRI as a predictor of infarct growth in acute ischemic stroke. J Nucl Med 41:788–794
Benamer HTS, Uk M, Patterson J, Grosset DG, Joseph K, Tatsch K, Schwarz J, Ries V (2000) Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging : the [123I]-FP-CIT study group. Mov Disord 15:503–510
Loos C, Achten E, Santens P (2010) Proton magnetic resonance spectroscopy in Alzheimer’s disease, a review. Acta Neurol Belg 110:291–298
Kantarci K, Weigand SD, Petersen RC et al (2007) Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging 28:1330–1339
Adalsteinsson E, Sullivan EV, Kleinhans N, Spielman DM, Pfefferbaum A (2000) Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer’s disease. Lancet 355:1695–1696
Voevodskaya O, Sundgren PC, Strandberg O, Zetterberg H, Minthon L, Blennow K, Wahlund LO, Westman E, Hansson O (2016) Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease. Neurology 86:1754–1761
Murray ME, Przybelski SA, Lesnick TG et al (2014) Early Alzheimer’s disease neuropathology detected by proton MR spectroscopy. J Neurosci 34:16247–16255
Wilson TW, Heinrichs-Graham E, Proskovec AL, McDermott TJ (2015) Neuroimaging with magnetoencephalography: a dynamic view of brain pathophysiology. Transl Res 175:17–36
Luck SJ (2005) An introduction to the event-related potential technique. MIT Press Ltd, Cambridge
Grynszpan F, Geselowitz DB (1973) Model studies of the magnetocardiogram. Biophys J 13:911–925
Cuffin N, Cohen D (1979) Comparison of the magnetoencephalogram and electroencephalogram. Electroencephalogr Clin Neurophysiol 47:132–146
Juckel G, Clotz F, Frodl T, Kawohl W, Hampel H, Pogarell O, Hegerl U (2008) Diagnostic usefulness of cognitive auditory event-related p300 subcomponents in patients with Alzheimers disease? J Clin Neurophysiol 25:147–152
Papadaniil CD, Kosmidou VE, Tsolaki A, Tsolaki M, Kompatsiaris IY, Hadjileontiadis LJ (2016) Cognitive MMN and P300 in mild cognitive impairment and Alzheimer’s disease: a high density EEG-3D vector field tomography approach. Brain Res 1648:425–433
Tallon-Baudry C, Bertrand O (1999) Oscillatory gamma activity in humans and its role in object representation. Trends Cogn Sci 3:151–162
Uhlhaas PJ, Haenschel C, Nikolić D, Singer W (2008) The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr Bull 34:927–943
Gevins A, Smith ME, McEvoy L, Yu D (1997) High-resolution EEG mapping of cortical activation related to working memory: effects of task difficulty, type of processing, and practice. Cereb Cortex 7:374–385
Klimesch W (2012) Alpha-band oscillations, attention, and controlled access to stored information. Trends Cogn Sci 16:606–617
Buzsáki G, Draguhn A (2004) Neuronal oscillations in cortical networks. Science 304:1926–1929
Stoffers D, Bosboom JLW, Deijen JB, Wolters EC, Stam CJ, Berendse HW (2008) Increased cortico-cortical functional connectivity in early-stage Parkinson’s disease: an MEG study. NeuroImage 41:212–222
Stam CJ (2010) Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders. J Neurol Sci 289:128–134
Greicius M, Seeley W, Carter AR, Shulman GL, Corbetta M (2012) Why use a connectivity-based approach to study stroke and recovery of function? NeuroImage 62:2271–2280
Smith SM, Beckmann CF, Andersson J et al (2013) Resting-state fMRI in the Human Connectome Project. NeuroImage 80:144–168
Union E (2014) The human brain project—human brain project. Hum Brain Proj Website. 50–55
Bassett DS, Sporns O (2017) Network neuroscience. Nat Neurosci 20:353–364
Bullmore E, Sporns O (2009) Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 10:186–198
Crossley NA, Mechelli A, Scott J, Carletti F, Fox PT, McGuire P, Bullmore ET (2014) The hubs of the human connectome are generally implicated in the anatomy of brain disorders. Brain. doi:10.1093/brain/awu132
Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, Andrews-Hanna JR, Sperling RA, Johnson KA (2009) Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer’s disease. J Neurosci 29:1860–1873
Fornito A, Bullmore ET, Zalesky A (2017) Opportunities and challenges for psychiatry in the connectomic era. Biol Psychiatry Cogn Neurosci Neuroimaging 2:9–19
Perlmutter JS, Mink JW (2006) Deep brain stimulation. Annu Rev Neurosci 29:229–257
Bronstein JM, Tagliati M, Alterman RL et al (2011) Deep brain stimulation for Parkinson disease. Arch Neurol 68:165–165
Delorme C, Rogers A, Lau B, Francisque H, Welter M-L, Vidal SF, Yelnik J, Durr A, Grabli D, Karachi C (2016) Deep brain stimulation of the internal pallidum in Huntington’s disease patients: clinical outcome and neuronal firing patterns. J Neurol 263:290–298
Edwards TC, Zrinzo L, Limousin P, Foltynie T (2012) Deep brain stimulation in the treatment of chorea. Mov Disord 27:357–363
Sankar T, Chakravarty MM, Bescos A et al (2015) Deep brain stimulation influences brain structure in Alzheimer’s disease. Brain Stimul 8:645–654
Parkin BL, Ekhtiari H, Walsh VF (2015) Non-invasive human brain stimulation in cognitive neuroscience: a primer. Neuron 87:932–945
Vallence AM, Ridding MC (2014) Non-invasive induction of plasticity in the human cortex: uses and limitations. Cortex 58:261–271
Hoyer EH, Celnik PA (2011) Understanding and enhancing motor recovery after stroke using transcranial magnetic stimulation. Restor Neurol Neurosci 29:395–409
Lefaucheur J-P, André-Obadia N, Antal A et al (2014) Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol 125:2150–2206
Jack CR, Bernstein MA, Fox NC et al (2008) The Alzheimer’s Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27:685–691
Rohrer JD, Nicholas JM, Cash DM et al (2015) Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the genetic frontotemporal dementia initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol 14:253–262
Woo C-W, Chang LJ, Lindquist MA, Wager TD (2017) Building better biomarkers: brain models in translational neuroimaging. Nat Neurosci 20:365–377
Miller KL, Alfaro-Almagro F, Bangerter NK et al (2016) Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat Neurosci 19:1523–1536
Bandettini P, Bullmore E (2012) The future of functional MRI in clinical medicine. NeuroImage 62:1267–1271
Acknowledgments
M.V. was supported by a grant from The Medical Research Council, project grant number MR/M023664/1. N.E. was supported by National Health and Medical Research Council project grant number APP1020526.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Veldsman, M., Egorova, N. (2017). Advances in Neuroimaging for Neurodegenerative Disease. In: Beart, P., Robinson, M., Rattray, M., Maragakis, N. (eds) Neurodegenerative Diseases. Advances in Neurobiology, vol 15. Springer, Cham. https://doi.org/10.1007/978-3-319-57193-5_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-57193-5_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57191-1
Online ISBN: 978-3-319-57193-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)